Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Classical hematology 1

Conditions

Lymphoma, Large B-Cell, Diffuse 2Lymphoma, Follicular 2Waldenstrom Macroglobulinemia 1Thrombocytopenia 1Sezary Syndrome 1Prostatic Neoplasms 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Myelodysplastic Syndromes 1Mycosis Fungoides 1Lymphoma, T-Cell, Peripheral 1Lymphoma, Mantle-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Extranodal NK-T-Cell 1Lymphoma, B-Cell, Marginal Zone 1Lymphoma 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Lymphocytic, Chronic, B-Cell 1Immunoblastic Lymphadenopathy 1Hodgkin Disease 1Burkitt Lymphoma 1Anemia, Refractory, with Excess of Blasts 1Anemia, Refractory 1

Interventions

eltrombopag 3romiplostim 2fludarabine phosphate 2Peripheral Blood Stem Cell Transplantation 2Cytarabine 2Busulfan 2Vitamin E 1Tranexamic Acid 1Topotecan 1Thrombopoietin 1Saline Solution 1Radiotherapy 1Moxibustion 1Microarray Analysis 1Isotretinoin 1Ifosfamide 1Gene Expression Profiling 1Flow Cytometry 1Filgrastim 1Etoposide 1Doxorubicin 1Decitabine 1DNA Methylation 1Cytogenetic Analysis 1Cord Blood Stem Cell Transplantation 1Carboplatin 1CP protocol 1Antilymphocyte Serum 1Amplified Fragment Length Polymorphism Analysis 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Thrombocytopenia × Amplified Fragment Length Polymorphism Analysis × Clear all
NCT01165996 2019-03-04

Differentiation Therapy With Decitabine in Treating Patients With Myelodysplastic Syndrome

Case Comprehensive Cancer Center

Phase 1/2 Completed
25 enrolled 13 charts
Classical hematologyMyeloidOther hematologic neoplasm

Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Myelodysplastic Syndromes, Thrombocytopenia, Leukemia, Myelomonocytic, Chronic

Data powered by HemOnc (CC BY 4.0) Colophon âš¡